NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting. Links to each presentation are included below. “We were pleased to present three encore presentations yesterday during the CMSC conference. We continue to be impressed by the BRIUMVI data and look forward to co ...

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Sparton Resources Inc. (SRI: TSX-V) (the “Company”) is pleased to announce that the Company and Eldorado Gold Corporation (“Eldorado”) have closed an agreement, effective May 29, 2025, whereunder Eldorado acquired the Company’s remaining 25% interest in the Bruell Gold Project 51 claim property in Vauquelin township, Quebec. (The Company and Eldorado are referred to jointly herein as “the Parties”.) All dollar figures stated are in Canadian Dollars. The Option Agree ...

Company Overview - Serve Robotics is a leading autonomous sidewalk delivery company focused on developing AI-powered, low-emissions delivery robots aimed at making delivery sustainable and economical [4] - The company was spun off from Uber in 2021 and has completed tens of thousands of deliveries for enterprise partners such as Uber Eats and 7-Eleven [4] - Serve Robotics has scalable multi-year contracts, including an agreement to deploy up to 2,000 delivery robots on the Uber Eats platform across multiple U.S. markets [4] Annual Meeting Details - The Annual Meeting of Stockholders will be held virtually on June 12, 2025, at noon PDT [1] - Stockholders of record as of April 14, 2025, will have the right to participate in the meeting [2] - The company commenced mailing the Notice to stockholders on April 25, 2025, which includes instructions for accessing the Proxy Statement and annual report, as well as voting options [3]

Core Viewpoint - Nexxen International Ltd. has successfully amended its revolving credit facility, reducing the committed facility size and extending the maturity date, which enhances its liquidity for business operations and strategic investments [1][2]. Company Overview - Nexxen is a global advertising technology platform specializing in data and advanced TV, offering a flexible technology stack that includes a demand-side platform (DSP) and supply-side platform (SSP) [3]. - The company is headquartered in Israel and has offices across the United States, Canada, Europe, and Asia-Pacific, and is publicly traded on Nasdaq under the ticker NEXN [4]. Financial Update - The committed facility size of Nexxen's revolving credit facility has been reduced from $90 million to $50 million, with the maturity extended to September 2027 [2]. - The company's strong cash position, combined with the updated credit facility, provides sufficient liquidity to support ongoing business needs and future strategic initiatives [2].

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, May 30, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that, in response to the notice received from Aditxt Inc. (“Aditxt”) on May 17, 2025, the Company has delivered formal notice to Aditxt to terminate the ...

CALGARY, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI, OTCQX:BDIMF), a leading provider of space rental and temporary lodging and accommodations, issued its 2025 Corporate Responsibility Report (the “Report”) detailing the Company’s commitment to environmental, social and governance matters, while highlighting the positive results and value delivered through the Company’s shared efforts. “We know that business is a powerful driver of econ ...

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil"), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced that Bronson Crouch, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference at 4:20PM ET on Thursday, June 5, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/jeff319/til/1708376. About Instil BioInstil Bio is a clinical-stage biopharmaceutical company f ...

Featuring top researchers and industry experts using high-throughput proteomics to drive breakthroughs in population health, translational research and clinical developmentSOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The series will spotlight thought leaders and industry expe ...

FREDERICK, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that the first participant has been enrolled in its Phase 3 AURORA trial of Descartes-08 in patients with myasthenia gravis (MG). Descartes-08, Cartesian’s lead cell therapy candidate, is an autologous engineered chimeric antigen receptor T-cell therapy (CAR-T) product candidate tar ...

New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight’s unique value propositionUpsized $20 million financing led by U.S. institutional investors is expected to fund key value inflection points through planned commercial launch of next-generation Novasight Hybrid™ System in H1 2026U.S. FDA 510(k) submission remains on track for calendar Q3 2025 TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) ...